Visual detection of transport-P in peptidergic neurones.
1. Hypothalamic peptidergic neurones possess an uptake process for amines (transport-P), for which prazosin is a substrate. It is characterized by a paradoxical increase in the accumulation of [3H]-prazosin when the concentration of unlabelled prazosin is increased above 10(-7) M. This increase is due to activation of a proton-dependent, vacuolar-type ATPase-linked pump that is blocked by tricyclic antidepressants. This study utilized a fluorescence method to detect amine uptake in individual cells. 2. Prazosin is fluorescent but most of its emission spectrum is in the ultraviolet range. We therefore used an analogue of prazosin in which the furan ring had been substituted with a fluorescent group, BODIPY FL. This compound's emission maximum is in the green part of the visible spectrum. 3. BODIPY FL prazosin accumulated in immortalised peptidergic neurones and the characteristic emission spectrum of the compound was evident in these cells. Accumulation of BODIPY FL prazosin was saturable and was inhibited by the tricyclic antidepressant desipramine and by unlabelled prazosin. As previously described for prazosin, uptake of BODIPY FL prazosin was blocked by cold temperature and by the organic base chloroquine. Thus, prazosin and BODIPY FL prazosin were accumulated by the same uptake process. 4. BODIPY FL prazosin accumulated in a granular distribution, which is compatible with storage in intracellular vesicles. 5. Hypothalamic cells from foetal rats in primary culture also accumulated BODIPY FL prazosin by a desipramine-sensitive process. Uptake was predominantly in neurones and glial cells did not accumulate the amine. 6. Fluorescent detection provides visual evidence for amine uptake in peptidergic neurones and should enable detailed study of the distribution of this process in the brain.
al-Damluji
S
S
Clinical Neuroscience Branch, N.I.N.D.S., National Institutes of Health, Bethesda, Maryland 20892, USA.
Porter
D
D
Krsmanovic
L Z
LZ
Knutson
J R
JR
Kopin
I J
IJ
D000317:Adrenergic alpha-Antagonists / Q000378:metabolism; D000588:Amines / Q000378:metabolism*; D000818:Animals; D001692:Biological Transport; D001896:Boron Compounds; D002461:Cell Line, Transformed; D003891:Desipramine / Q000494:pharmacology; D005456:Fluorescent Dyes; D007031:Hypothalamus / Q000166:cytology / Q000196:embryology / Q000378:metabolism; D008856:Microscopy, Fluorescence; D009474:Neurons / Q000378:metabolism*; D010455:Peptides / Q000378:metabolism*; D011224:Prazosin / Q000037:antagonists & inhibitors / Q000378:metabolism; D051381:Rats; D018340:Receptors, Adrenergic, alpha-1 / Q000378:metabolism; D013050:Spectrometry, Fluorescence
C095489:4,4-difluoro-4-bora-3a,4a-diaza-s-indacene; D000317:Adrenergic alpha-Antagonists; D000588:Amines; D001896:Boron Compounds; D005456:Fluorescent Dyes; D010455:Peptides; D018340:Receptors, Adrenergic, alpha-1; D003891:Desipramine; D011224:Prazosin